194 related articles for article (PubMed ID: 33016514)
1. Evaluation of efficacy of QR678
Kapoor R; Shome D; Doshi K; Vadera S; Patel G; Kumar V
J Cosmet Dermatol; 2020 Dec; 19(12):3270-3279. PubMed ID: 33016514
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of efficacy of QR 678 and QR678 neo hair growth factor formulation for the treatment of female pattern alopecia in patients with PCOS-A prospective study.
Kapoor R; Shome D; Doshi K; Patel G; Vadera S
J Cosmet Dermatol; 2020 Oct; 19(10):2637-2646. PubMed ID: 33460214
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of QR678 Neo
Shome D; Kapoor R; Surana M; Vadera S; Shah R
J Cosmet Dermatol; 2022 Jan; 21(1):16-23. PubMed ID: 34875139
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of QR678 and QR678 Neo
Shome D; Kapoor R; Doshi K; Patel G; Vadera S; Kumar V
J Cosmet Dermatol; 2022 Jan; 21(1):358-367. PubMed ID: 34825770
[TBL] [Abstract][Full Text] [Related]
5. QR 678 & QR678 Neo Vs PRP-A randomised, comparative, prospective study.
Kapoor R; Shome D; Vadera S; Ram MS
J Cosmet Dermatol; 2020 Nov; 19(11):2877-2885. PubMed ID: 32333510
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the safety and effectiveness of intradermal administration of QR678 Neo
Clinic A; Asper A; Mittal A; Shome D; Parbhoo D; Thanzama J; Doshi K; Sachde N; Gaunkar R; Kapoor R; Thakkar R; Sion S; Shetty S; Kumar V; Parveen V; Singhal V
J Cosmet Dermatol; 2022 Feb; 21(2):580-589. PubMed ID: 34997995
[TBL] [Abstract][Full Text] [Related]
7. QR678 & QR678 Neo Hair Growth Formulations: A Cellular Toxicity & Animal Efficacy Study.
Kapoor R; Shome D; Vadera S; Kumar V; Ram MS
Plast Reconstr Surg Glob Open; 2020 Aug; 8(8):e2843. PubMed ID: 32983753
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of efficacy of intradermal injection therapy vs derma roller application for administration of QR678 Neo
Shome D; Kapoor R; Vadera S; Doshi K; Patel G; Mohammad Khan T
J Cosmet Dermatol; 2021 Oct; 20(10):3299-3307. PubMed ID: 33826786
[TBL] [Abstract][Full Text] [Related]
9. A newer approach in the treatment of seborrheic dermatitis with QR678® and QR678 Neo®-A prospective pilot study.
Kapoor R; Shome D; Doshi K; Patel G; Tandel H; Kumar V
J Cosmet Dermatol; 2023 Nov; 22(11):3078-3087. PubMed ID: 37621248
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
[TBL] [Abstract][Full Text] [Related]
11. "Comparison of QR 678
Shome D; Kapoor R; Doshi K; Patel G; Vadera S; Kumar V
J Cosmet Dermatol; 2021 Jun; 20(6):1763-1765. PubMed ID: 33864424
[No Abstract] [Full Text] [Related]
12. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
[TBL] [Abstract][Full Text] [Related]
13. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.
Smetanay K; Junio P; Feißt M; Seitz J; Hassel JC; Mayer L; Matthies LM; Schumann A; Hennigs A; Heil J; Sohn C; Jaeger D; Schneeweiss A; Marmé F
Breast Cancer Res Treat; 2019 Jan; 173(1):135-143. PubMed ID: 30255454
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of hair recovery after (neo)adjuvant chemotherapy with scalp cooling in Japanese breast cancer patients.
Ohsumi S; Kiyoto S; Takahashi M; Takashima S; Aogi K; Shimizu S; Doi M
Support Care Cancer; 2021 Oct; 29(10):6119-6125. PubMed ID: 33797582
[TBL] [Abstract][Full Text] [Related]
15. Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy.
Ohsumi S; Kiyoto S; Takahashi M; Hara F; Takashima S; Aogi K; Matsuda M; Yamamura N; Doi M
Support Care Cancer; 2021 Jan; 29(1):437-443. PubMed ID: 32388615
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of efficacy of derma roller sizes vs topical application for administration of QR678 Neo® hair regrowth formulation in the treatment of androgenetic alopecia.
Shome D; Tandel H; Kumar V; Kapoor R
J Cosmet Dermatol; 2022 Nov; 21(11):6528-6530. PubMed ID: 36069359
[No Abstract] [Full Text] [Related]
17. Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth - safety and efficacy evaluation in a first-in-man pilot clinical study.
Kapoor R; Shome D
J Cosmet Laser Ther; 2018 Oct; 20(6):369-379. PubMed ID: 29482481
[TBL] [Abstract][Full Text] [Related]
18. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
Nangia J; Wang T; Osborne C; Niravath P; Otte K; Papish S; Holmes F; Abraham J; Lacouture M; Courtright J; Paxman R; Rude M; Hilsenbeck S; Osborne CK; Rimawi M
JAMA; 2017 Feb; 317(6):596-605. PubMed ID: 28196254
[TBL] [Abstract][Full Text] [Related]
19. Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT).
Kang D; Kim IR; Park YH; Im YH; Zhao D; Guallar E; Ahn JS; Cho J
Support Care Cancer; 2020 Apr; 28(4):1829-1837. PubMed ID: 31338640
[TBL] [Abstract][Full Text] [Related]
20. Patient-reported outcome assessment and objective evaluation of chemotherapy-induced alopecia.
Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Smorenburg CH; van der Hoeven JJM
Eur J Oncol Nurs; 2018 Apr; 33():49-55. PubMed ID: 29551177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
